Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Oral Sci ; 10(3): 25, 2018 09 03.
Article in English | MEDLINE | ID: mdl-30174329

ABSTRACT

Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients' ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10 mg·kg-1 sertraline in drinking water, n = 26) or without (control, n = 30) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5 ng BMP2. SSRI exposure continued until sacrifice in the exposed groups at 4 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.


Subject(s)
Osteogenesis , Selective Serotonin Reuptake Inhibitors , Sertraline , Skull , Wound Healing , Animals , Male , Mice , Apoptosis , Bone Morphogenetic Protein 2 , Cell Culture Techniques , Cell Proliferation , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Mice, Inbred C57BL , Osteogenesis/drug effects , Random Allocation , Real-Time Polymerase Chain Reaction , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/pharmacology , Sertraline/adverse effects , Sertraline/pharmacology , Skull/diagnostic imaging , Skull/drug effects , Skull/injuries , Wound Healing/drug effects , X-Ray Microtomography
2.
Calcif Tissue Int ; 101(3): 300-311, 2017 09.
Article in English | MEDLINE | ID: mdl-28391432

ABSTRACT

Thyroid hormone is important for skull bone growth, which primarily occurs at the cranial sutures and synchondroses. Thyroid hormones regulate metabolism and act in all stages of cartilage and bone development and maintenance by interacting with growth hormone and regulating insulin-like growth factor. Aberrant thyroid hormone levels and exposure during development are exogenous factors that may exacerbate susceptibility to craniofacial abnormalities potentially through changes in growth at the synchondroses of the cranial base. To elucidate the direct effect of in utero therapeutic thyroxine exposure on the synchondroses in developing mice, we provided scaled doses of the thyroid replacement drug, levothyroxine, in drinking water to pregnant C57BL6 wild-type dams. The skulls of resulting pups were subjected to micro-computed tomography analysis revealing less bone volume relative to tissue volume in the synchondroses of mouse pups exposed in utero to levothyroxine. Histological assessment of the cranial base area indicated more active synchondroses as measured by metabolic factors including Igf1. The cranial base of the pups exposed to high levels of levothyroxine also contained more collagen fiber matrix and an increase in markers of bone formation. Such changes due to exposure to exogenous thyroid hormone may drive overall morphological changes. Thus, excess thyroid hormone exposure to the fetus during pregnancy may lead to altered craniofacial growth and increased risk of anomalies in offspring.


Subject(s)
Prenatal Exposure Delayed Effects/pathology , Skull Base/drug effects , Skull Base/growth & development , Thyroxine/toxicity , Animals , Female , Male , Mice , Mice, Inbred C57BL , Pregnancy , Thyroid Hormones/toxicity , X-Ray Microtomography
3.
PLoS One ; 11(12): e0167805, 2016.
Article in English | MEDLINE | ID: mdl-27959899

ABSTRACT

Large scale surveillance studies, case studies, as well as cohort studies have identified the influence of thyroid hormones on calvarial growth and development. Surveillance data suggests maternal thyroid disorders (hyperthyroidism, hypothyroidism with pharmacological replacement, and Maternal Graves Disease) are linked to as much as a 2.5 fold increased risk for craniosynostosis. Craniosynostosis is the premature fusion of one or more calvarial growth sites (sutures) prior to the completion of brain expansion. Thyroid hormones maintain proper bone mineral densities by interacting with growth hormone and aiding in the regulation of insulin like growth factors (IGFs). Disruption of this hormonal control of bone physiology may lead to altered bone dynamics thereby increasing the risk for craniosynostosis. In order to elucidate the effect of exogenous thyroxine exposure on cranial suture growth and morphology, wild type C57BL6 mouse litters were exposed to thyroxine in utero (control = no treatment; low ~167 ng per day; high ~667 ng per day). Thyroxine exposed mice demonstrated craniofacial dysmorphology (brachycranic). High dose exposed mice showed diminished area of the coronal and widening of the sagittal sutures indicative of premature fusion and compensatory growth. Presence of thyroid receptors was confirmed for the murine cranial suture and markers of proliferation and osteogenesis were increased in sutures from exposed mice. Increased Htra1 and Igf1 gene expression were found in sutures from high dose exposed individuals. Pathways related to the HTRA1/IGF axis, specifically Akt and Wnt, demonstrated evidence of increased activity. Overall our data suggest that maternal exogenous thyroxine exposure can drive calvarial growth alterations and altered suture morphology.


Subject(s)
Cranial Sutures/drug effects , Prenatal Exposure Delayed Effects/pathology , Thyroxine/adverse effects , Animals , Female , High-Temperature Requirement A Serine Peptidase 1 , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Male , Mice , Mice, Inbred C57BL , Pregnancy , Prenatal Exposure Delayed Effects/diagnostic imaging , Prenatal Exposure Delayed Effects/metabolism , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Wnt Signaling Pathway/genetics
4.
Birth Defects Res A Clin Mol Teratol ; 106(10): 803-813, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27435288

ABSTRACT

BACKGROUND: Craniosynostosis, the premature fusion of one or more of the cranial sutures, is estimated to occur in 1:1800 to 2500 births. Genetic murine models of craniosynostosis exist, but often imperfectly model human patients. Case, cohort, and surveillance studies have identified excess thyroid hormone as an agent that can either cause or exacerbate human cases of craniosynostosis. METHODS: Here we investigate the influence of in utero and in vitro exogenous thyroid hormone exposure on a murine model of craniosynostosis, Twist 1 +/-. RESULTS: By 15 days post-natal, there was evidence of coronal suture fusion in the Twist 1 +/- model, regardless of exposure. With the exception of craniofacial width, there were no significant effects of exposure; however, the Twist 1 +/- phenotype was significantly different from the wild-type control. Twist 1 +/- cranial suture cells did not respond to thyroxine treatment as measured by proliferation, osteogenic differentiation, and gene expression of osteogenic markers. However, treatment of these cells did result in modulation of thyroid associated gene expression. CONCLUSION: Our findings suggest the phenotypic effects of the genetic mutation largely outweighed the effects of thyroxine exposure in the Twist 1 +/- model. These results highlight difficultly in experimentally modeling gene-environment interactions for craniosynostotic phenotypes. Birth Defects Research (Part A) 106:803-813, 2016. © 2016 Wiley Periodicals, Inc.


Subject(s)
Abnormalities, Drug-Induced , Craniosynostoses , Gene-Environment Interaction , Nuclear Proteins/genetics , Phenotype , Thyroxine/adverse effects , Twist-Related Protein 1/genetics , Abnormalities, Drug-Induced/genetics , Abnormalities, Drug-Induced/metabolism , Abnormalities, Drug-Induced/pathology , Animals , Craniosynostoses/chemically induced , Craniosynostoses/genetics , Craniosynostoses/metabolism , Craniosynostoses/pathology , Disease Models, Animal , Gene Expression Regulation , Mice , Mice, Mutant Strains , Osteogenesis/drug effects , Osteogenesis/genetics , Thyroxine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...